These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 471867)

  • 21. The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).
    Sinclair J; Forbes CD; Prentice CR; Scott R
    Urol Res; 1976 Nov; 4(3):129-31. PubMed ID: 797086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation.
    Geltzeiler J; Schwartz D
    Urology; 1984 Jul; 24(1):64-6. PubMed ID: 6740850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ejaculation due to epsilon aminocaproic acid.
    Evans BE; Aledort LM
    N Engl J Med; 1978 Jan; 298(3):166-7. PubMed ID: 619254
    [No Abstract]   [Full Text] [Related]  

  • 24. Aminocaproic acid myopathy.
    Swash M
    Br Med J; 1980 Aug; 281(6237):454. PubMed ID: 7427315
    [No Abstract]   [Full Text] [Related]  

  • 25. Myopathy from E-aminocaproic acid: a second case.
    Bennett JR
    Postgrad Med J; 1972 Jul; 48(561):440-2. PubMed ID: 5069902
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid.
    Pitts TO; Spero JA; Bontempo FA; Greenberg A
    Am J Kidney Dis; 1986 Dec; 8(6):441-4. PubMed ID: 3812474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fatal massive intravascular coagulation during phlebography. Responsibility of epsilon-aminocaproic acid?].
    Coste F; Tremolières F; Bousquet M; Martin E; Dreyfuss D; Levesque M; Barge J
    Presse Med; 1985 Apr; 14(15):832-4. PubMed ID: 3158905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.
    Achiron A; Gornish M; Melamed E
    Stroke; 1990 May; 21(5):817-9. PubMed ID: 2339463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute necrotising myopathy associated with amiodarone therapy.
    Clouston PD; Donnelly PE
    Aust N Z J Med; 1989 Oct; 19(5):483-5. PubMed ID: 2590102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive muscle necrosis after long-term treatment with aminocaproic acid (EACA) in a case of hereditary periodic edema.
    Korsan-Bengtsen K; Ysander L; Blohmé G; Tibblin E
    Acta Med Scand; 1969 Apr; 185(4):341-6. PubMed ID: 4980341
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thrombosis.
    Tahmouresie A
    J Neurosurg; 1979 Aug; 51(2):266. PubMed ID: 448439
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral thrombosis associated with Amicar therapy.
    Hoffman EP; Koo AH
    Radiology; 1979 Jun; 131(3):687-9. PubMed ID: 441374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of probenecid on the kinetics of epsilon-aminocaproic acid.
    Dvorchik BH; Katlic KL; Hayes AH; Eyster ME
    Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral essential hematuria. Therapy with epsilon aminocaproic acid.
    Nash DA; Henry AR
    Urology; 1984 Mar; 23(3):297-8. PubMed ID: 6702043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensive thrombosis following central venous catheterization--a relationship to antifibrinolytic therapy?
    Hayhurst MD
    S Afr Med J; 1983 May; 63(21):797. PubMed ID: 6845102
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage.
    Chowdhary UM; Sayed K
    J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [RESULTS OF THERAPY WITH EPSILON AMINOCAPROIC ACID (EACA) IN 2 CASES OF REFRACTORY PURPURA].
    LAUGIER P; RISOLD JC
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():647-8. PubMed ID: 14266366
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyolysis induced by epsilon-aminocaproic acid.
    Seymour BD; Rubinger M
    Ann Pharmacother; 1997 Jan; 31(1):56-8. PubMed ID: 8997467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.